Intravascular Stents Market Size, Share, Trends, Growth Outlook

Intravascular Stents Market is estimated to increase at a growth rate of 8.3% CAGR over the forecast period from 2024 to 2030.

The Intravascular Stents Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents), By Mode of Delivery (Self-expanding Stents, Balloon-expandable Stents), By Product (Coronary Stents, Peripheral Stents, Neurovascular Stents), By End-User (Hospital & Cardiac Centers & Ambulatory Surgical Centers, Ambulatory Surgical Centers, Others).

An Introduction to Intravascular Stents Market in 2024

The Intravascular Stents market in 2024 continues to evolve as a cornerstone of interventional cardiology, offering effective solutions for coronary and peripheral artery disease management. Intravascular stents, ranging from bare-metal to drug-eluting and bioresorbable scaffolds, play a crucial role in restoring vessel patency, preventing restenosis, and improving long-term clinical outcomes following percutaneous coronary intervention (PCI) and peripheral vascular interventions. The market is witnessing a paradigm shift towards next-generation stent platforms characterized by thinner struts, biocompatible coatings, and enhanced drug delivery systems, thereby minimizing stent-related complications and optimizing vascular healing. Moreover, ongoing research endeavors are exploring innovative stent designs and materials, including bioabsorbable polymers and nanotechnology-based coatings, to further improve stent performance and patient compatibility, ushering in a new era of precision medicine in cardiovascular care.

Intravascular Stents Market Trend: Shift towards Bioresorbable Stents and Drug-Eluting Stents

A prominent trend in the Intravascular Stents market is the increasing adoption of bioresorbable stents and drug-eluting stents (DES). Manufacturers are focusing on developing stents with advanced features such as bioresorbable materials that gradually dissolve after fulfilling their purpose, reducing the risk of long-term complications. Additionally, drug-eluting stents, which release medication to prevent restenosis, are gaining popularity for their ability to improve patient outcomes by reducing the need for repeat procedures. This trend reflects a growing preference for stents that offer improved biocompatibility, reduced inflammation, and enhanced long-term efficacy.

Market Driver: Rising Prevalence of Cardiovascular Diseases and Coronary Artery Disease

A key driver fueling the Intravascular Stents market is the increasing prevalence of cardiovascular diseases (CVDs) and coronary artery disease (CAD) globally. Factors such as sedentary lifestyles, unhealthy dietary habits, tobacco use, and aging populations contribute to the growing burden of CVDs and CAD. As intravascular stents play a crucial role in the treatment of obstructive coronary artery lesions, there is a rising demand for stent implantation procedures to restore blood flow, relieve symptoms, and improve patient outcomes. The growing incidence of CAD underscores the need for effective stenting solutions, driving market growth.

Intravascular Stents Market Opportunity: Expansion into Emerging Markets and Developing Regions

An opportunity in the Intravascular Stents market lies in the expansion into emerging markets and developing regions with unmet medical needs. While the adoption of intravascular stents is well-established in developed healthcare markets, there is significant potential for growth in emerging economies where the burden of CAD is increasing, but access to advanced treatment options remains limited. By strategically entering these markets, manufacturers can address the unmet needs of patients, collaborate with local healthcare providers to enhance awareness and education about CAD management, and contribute to improving patient outcomes on a global scale. Expanding market presence in emerging regions presents an opportunity for revenue growth and market expansion while fulfilling an important healthcare need.

Intravascular Stents Market Segmentation

By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Intravascular Stents Market Companies

Abbott
B Braun Melsungen AG
Biotronik
Boston Scientific Inc
Cook Medical
Hellman & Friedman (Cordis Inc)
iVascular SLU
Lifetech
Medtronic
Microport Scientific Corp
Stentys S.A.
Stryker
Terumo Medical

 

 

Reasons to Buy the Intravascular Stents Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Intravascular Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Intravascular Stents Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Intravascular Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Intravascular Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Intravascular Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Intravascular Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Intravascular Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Intravascular Stents Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Intravascular Stents Market Industry
4.2 Key Market Trends in Intravascular Stents Market Industry
4.3 Potential Opportunities in Intravascular Stents Market Industry
4.4 Key Challenges in Intravascular Stents Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Intravascular Stents Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Intravascular Stents Market Outlook By Segments
7.1 Intravascular Stents Market Outlook by Segments
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

8 North America Intravascular Stents Market Analysis And Outlook To 2030
8.1 Introduction to North America Intravascular Stents Markets in 2024
8.2 North America Intravascular Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Intravascular Stents Market size Outlook by Segments, 2021-2030
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

9 Europe Intravascular Stents Market Analysis And Outlook To 2030
9.1 Introduction to Europe Intravascular Stents Markets in 2024
9.2 Europe Intravascular Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Intravascular Stents Market Size Outlook By Segments, 2021-2030
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

10 Asia Pacific Intravascular Stents Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Intravascular Stents Markets in 2024
10.2 Asia Pacific Intravascular Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Intravascular Stents Market size Outlook by Segments, 2021-2030
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

11 South America Intravascular Stents Market Analysis And Outlook To 2030
11.1 Introduction to South America Intravascular Stents Markets in 2024
11.2 South America Intravascular Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Intravascular Stents Market size Outlook by Segments, 2021-2030
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

12 Middle East And Africa Intravascular Stents Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Intravascular Stents Markets in 2024
12.2 Middle East and Africa Intravascular Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Intravascular Stents Market size Outlook by Segments, 2021-2030
By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
B Braun Melsungen AG
Biotronik
Boston Scientific Inc
Cook Medical
Hellman & Friedman (Cordis Inc)
iVascular SLU
Lifetech
Medtronic
Microport Scientific Corp
Stentys S.A.
Stryker
Terumo Medical

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Drug Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioabsorbable Stents
By Mode of Delivery
Self-expanding Stents
Balloon-expandable Stents
By Product Scope
Coronary Stents
Peripheral Stents
-Iliac Artery Stents
-Femoral Artery Stents
-Carotid Artery Stents
-Renal Artery Stents
-Others
Neurovascular Stents
-Intracranial Stents
-Flow Diverters
By End-User
Hospital & Cardiac Centers & Ambulatory Surgical Centers
Ambulatory Surgical Centers
Others